Neurologic Manifestations of Primary Sjogren Syndrome.
Margaretten M.
Rheum Dis Clin North Am. 2017 Nov;43(4):519-529. doi: 10.1016/j.rdc.2017.06.002. Epub 2017 Aug 23.
Sjogren's syndrome: a neurological perspective.
Barsottini OGP, Moraes MPM, Fraiman PHA, Marussi VHR, Souza AWS, Braga Neto P, Spitz M.
Arq Neuropsiquiatr. 2023 Dec;81(12):1077-1083. doi: 10.1055/s-0043-1777105. Epub 2023 Dec 29.
Sjogren's syndrome.
Fox RI.
Lancet. 2005 Jul 23-29;366(9482):321-31. doi: 10.1016/S0140-6736(05)66990-5.
Acute hyperviscosity: syndromes and management.
Gertz MA.
Blood. 2018 Sep 27;132(13):1379-1385. doi: 10.1182/blood-2018-06-846816. Epub 2018 Aug 13.
Clinical features and high-risk indicators of central nervous system involvement in primary Sjogren's syndrome.
Fan W, Par-Young J, Li K, Zhang Y, Xiao P, Hua L, Leng L, Chen X, Bucala R.
Clin Rheumatol. 2023 Feb;42(2):443-451. doi: 10.1007/s10067-022-06448-w. Epub 2022 Nov 19.
Frequent involvement of central nervous system in primary Sjogren syndrome.
Moreira I, Teixeira F, Martins Silva A, Vasconcelos C, Farinha F, Santos E.
Rheumatol Int. 2015 Feb;35(2):289-94. doi: 10.1007/s00296-014-3097-9. Epub 2014 Jul 24.
Treatment of central nervous system involvement associated with primary Sjogren's syndrome.
Ozgocmen S, Gur A.
Curr Pharm Des. 2008;14(13):1270-3. doi: 10.2174/138161208799316366.
Sjogren's syndrome. Association of cutaneous vasculitis with central nervous system disease.
Alexander E, Provost TT.
Arch Dermatol. 1987 Jun;123(6):801-10. doi: 10.1001/archderm.123.6.801.
Imaging characteristics of Sjogren's syndrome.
Wang KY, Wintermark M, Penta M.
Clin Imaging. 2022 Dec;92:7-18. doi: 10.1016/j.clinimag.2022.08.022. Epub 2022 Sep 16.
The kaleidoscope of neurological manifestations in primary Sjogren's syndrome.
Alunno A, Carubbi F, Bartoloni E, Cipriani P, Giacomelli R, Gerli R.
Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):192-198. Epub 2019 Aug 28.
